Silo Pharma, Inc. · NASDAQ:SILO
Anson Funds Management LP reported a 7.20% stake in Silo Pharma, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Anson Funds Management LP reported a 7.20% stake in Silo Pharma, Inc., 952,381 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 7.20%
- Shares
- 952,381
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Anson Funds Management LP | 7.20% | 952,381 |
| Anson Management GP LLC | 7.20% | 952,381 |
| Tony Moore | 7.20% | 952,381 |
| Anson Advisors Inc. | 7.20% | 952,381 |
| Amin Nathoo | 7.20% | 952,381 |
| Moez Kassam | 7.20% | 952,381 |
Source
Related
- Silo Pharma, Inc.
- Anson Funds Management LP
- Silo Pharma, Inc. shareholders
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026
- Schedule 13G/A · SEG Opportunity Fund, LLC · Feb 13, 2026
- Schedule 13G/A · Mitchell P. Kopin · Feb 13, 2026
- Schedule 13G/A · Mitchell P. Kopin · Nov 7, 2025
- Schedule 13G · SEG Opportunity Fund, LLC · Oct 3, 2025
- Schedule 13G/A · Mitchell P. Kopin · Aug 12, 2025